A common arthritis drug, Etanercept, might be capable of doing double duty. According to a newly published study, individuals with mild to moderate Alzheimer's disease did not deteriorate in terms or cognition or behavior when they were given Etanercept every week for six months.
Etanercept blocks a blood protein that is released as part of an inflammatory response. High levels of this protein have been associated with worsening Alzheimer's disease.
The researchers are calling for further trials.
To learn more, click here.
Since 1968, Professional Medical has been a dedicated supplier to the long-term care industry. Our education, resources and products are designed to make improving care easier!
Posts
0 comments:
Post a Comment